JP Morgan Chase’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-60,164
Closed -$196K 7413
2022
Q4
$196K Buy
60,164
+58,445
+3,400% +$275K ﹤0.01% 5048
2022
Q3
$14K Hold
1,719
﹤0.01% 5904
2022
Q2
$36K Hold
1,719
﹤0.01% 5756
2022
Q1
$76K Sell
1,719
-14
-0.8% -$1.37K ﹤0.01% 5628
2021
Q4
$101K Sell
1,733
-6
-0.3% -$448 ﹤0.01% 5676
2021
Q3
$137K Buy
1,739
+20
+1% +$2.11K ﹤0.01% 5418
2021
Q2
$221K Buy
+1,719
New +$218K ﹤0.01% 5188

Other funds holding GMVD

JP Morgan Chase's GMVD Position: Q1 2023 in Review

JP Morgan Chase sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q1 2023, closing a stake of 60,164 shares — an estimated $196K sold.

JP Morgan Chase first reported a position in GMVD in Q2 2021 and held it in 7 quarters. The position peaked at $221K in Q2 2021. 9 funds tracked by Wall St. Rank hold GMVD as of Q1 2023.

  • JP Morgan Chase reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 60,164 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q1 2023, an estimated $196K.
  • JP Morgan Chase first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q2 2021 and held it in 7 quarters.
  • JP Morgan Chase's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $221K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.